Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelin and pulmonary hypertension.

Y F Chen1, S Oparil

  • 1Department of Medicine, Birmingham, Alabama, USA.

Journal of Cardiovascular Pharmacology
|September 8, 2000
PubMed
Summary

Endothelin-1 (ET-1) is upregulated in the lungs during hypoxia, mediating pulmonary hypertension and vascular remodeling. Blocking ET-1 receptors can prevent and reverse these effects, suggesting a therapeutic target for hypoxic pulmonary hypertension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive Blood Pressure Management Preserves Functional Connectivity in Patients with Hypertension from the Systolic Blood Pressure Intervention Randomized Trial.

AJNR. American journal of neuroradiology·2023
Same author

Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.

Journal of human hypertension·2014
Same author

Relationships between metrics of visit-to-visit variability of blood pressure.

Journal of human hypertension·2013
Same author

Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.

Journal of human hypertension·2011

Area of Science:

  • Cardiovascular Physiology
  • Pulmonary Medicine
  • Molecular Biology

Background:

  • Endothelin-1 (ET-1) and its receptors are upregulated in the lung under hypoxic conditions.
  • ET-1 is implicated as a key mediator of hypoxia-induced pulmonary vasoconstriction and vascular remodeling.

Purpose of the Study:

  • To investigate the role of ET-1 in hypoxia-induced pulmonary hypertension.
  • To evaluate the efficacy of ET-receptor antagonists in preventing and reversing hypoxic pulmonary vascular changes.

Main Methods:

  • Biochemical and molecular biological assays to measure ET-1 and receptor expression.
  • Functional studies on pulmonary artery pressure and vascular remodeling in hypoxic rats.
  • Administration of ET(A)-selective and combined ET(A)/ET(B) receptor antagonists.

Main Results:

  • Hypoxia stimulates ET-1 gene transcription and peptide synthesis.
  • Increased ET-1 and its receptor mRNA levels were observed in the lungs of hypoxic rats.
  • ET-receptor antagonists prevented and reversed hypoxia-induced pulmonary hypertension and vascular remodeling.

Conclusions:

  • Endogenous ET-1 plays a significant role in mediating hypoxic pulmonary vasoconstriction, hypertension, and vascular remodeling.
  • ET-receptor blockers show potential as therapeutic agents for preventing and treating human hypoxic pulmonary hypertension.

Related Experiment Videos